Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors
Open Access
- 14 August 2021
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (1) , e272-e280
Abstract
Context: Testicular adrenal rest tumors (TART) are a common complication in males with classic 21-hydroxylase deficiency (21OHD). TART are likely to contribute to the androgen excess in 21OHD patients, but a direct quantification of steroidogenesis from these tumors has not been yet done. Objective: We aimed to define the production of 11-oxygenated 19-carbon (11oxC19) steroids by TART. Methods: Using liquid chromatography-tandem mass spectrometry, steroids were measured in left (n = 7) and right (n = 4) spermatic vein and simultaneously drawn peripheral blood (n = 7) samples from 7 men with 21OHD and TART. For comparison, we also measured the peripheral steroid concentrations in 5 adrenalectomized patients and 12 age- and BMI-matched controls. Additionally, steroids were quantified in TART cell– and adrenal cell–conditioned medium, with and without adrenocorticotropic hormone (ACTH) stimulation. Results: Compared with peripheral blood from 21OHD patients with TART, the spermatic vein samples displayed the highest gradient for 11β-hydroxytestosterone (11OHT; 96-fold) of the 11oxC19 steroids, followed by 11-ketotestosterone (47-fold) and 11β-hydroxyandrostenedione (11OHA4; 29-fold), suggesting production of these steroids in TART. TART cells produced higher levels of testosterone and lower levels of A4 and 11OHA4 after ACTH stimulation compared with adrenal cells, indicating ACTH-induced production of testosterone in TART. Conclusion: In patients with 21OHD, TART produce 11oxC19 steroids, but in different proportions than the adrenals. The very high ratio of 11OHT in spermatic vs peripheral vein blood suggests the 11-hydroxylation of testosterone by TART, and the in vitro results indicate that this metabolism is ACTH-sensitive.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK109116)
This publication has 29 references indexed in Scilit:
- 11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: A putative role in castration resistant prostate cancer?Molecular and Cellular Endocrinology, 2013
- Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damageFertility and Sterility, 2008
- Testicular Tumors in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Show Functional Features of Adrenocortical TissueThe Journal of Clinical Endocrinology & Metabolism, 2007
- Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-Deoxycortisol in Classic Congenital Adrenal Hyperplasia: Clinical and Hormonal Correlations and Identification of Patients with 11β-Hydroxylase Deficiency among a Large Group with Alleged 21-Hydroxylase DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2006
- Testicular adrenal rest tumours in salt wasting congenital adrenal hyperplasia (in vivo and in vitro studies)The Journal of Steroid Biochemistry and Molecular Biology, 2005
- Expression of 11β-Hydroxylase in Rat Leydig CellsEndocrinology, 2002
- Gonadal and adrenal catheterization during adrenal suppression and gonadal stimulation in a patient with bilateral testicular tumors and congenital adrenal hyperplasia.The Journal of Clinical Endocrinology & Metabolism, 1994
- Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Journal of Clinical Investigation, 1992
- Steroidogenic Enzyme Activities, Morphology, and Receptor Studies of a Testicular Adrenal Rest in a Patient with Congenital Adrenal HyperplasiaThe Journal of Clinical Endocrinology & Metabolism, 1990
- True Precocious Puberty Complicating Congenital Adrenal Hyperplasia: Treatment with a Luteinizing Hormone-Releasing Hormone Analog*The Journal of Clinical Endocrinology & Metabolism, 1984